Accident Prevention Program Sample Clauses

Accident Prevention Program. Within seven (7) days after receipt of Notice of Award of the contract, and at least seven (7) days prior to the pre-work conference, two
AutoNDA by SimpleDocs
Accident Prevention Program. Within 10 days after receipt of Notice of Award of the contract, a searchable digital version of the Accident Prevention Program shall be submitted to the Contracting Officer for review and acceptance. Before initiation of work on the contract, a site specific, Accident Prevention Plan (APP) with appropriate appendices written in English by the Prime Contractor for the specific work and hazards of the contract, and implementing in detail the pertinent requirements of the most recent edition of EM 385-1-1 will be reviewed and found acceptable by the Government Designated Authority (GDA). APPs shall be developed and submitted by the Contractor in the formats provided in the most recent edition of EM 385-1-1. The Contractor shall address each of the elements/sub-elements in the outline contained in the order that they are provided in the manual. If by the nature of the work an item is not applicable, the Contractor shall state and provide a justification for why that element/sub-element is not applicable. The APP shall be developed by qualified personnel and shall be signed in accordance with EM 385-1-1. The Contractor shall be responsible for documenting the qualified person’s credentials. The Contractor’s APP shall be job-specific and shall include work to be performed by subcontractors and measures to be taken by the Contractor to control hazards associated with materials, services, or equipment provided by suppliers. The Contractor shall not commence physical work at the site until the program has been accepted by the Contracting Officer, or his/her authorized representative.
Accident Prevention Program. Prior to commencing work, the Contractor will develop and submit an Accident Prevention Program utilizing the form located in Appendix D.
Accident Prevention Program. The Bidder shall submit with the Responsibility Detail & Attestation Form, a copy of the Bidder’s Accident Prevention Program “APP” that meets the requirements stated in Section 01062, Washington Administrative Code (WAC) 000-000-000, and the applicable portions of WAC 296-24, WAC 296-62, WAC 296-67, WAC 296-155 and WAC 296-800. The County will review the APP. Should the County have concerns about the information contained in the APP, the County may request additional information and/or a submission of a revised APP.
Accident Prevention Program 

Related to Accident Prevention Program

  • Data Loss Prevention Transfer Agent shall implement a data leakage program that is designed to identify, detect, monitor and document Fund Data leaving Transfer Agent’s control without authorization in place.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Compliance Program The Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

  • Disaster Recovery Plan Contractor agrees that upon request of System Agency, Contractor shall provide copies of its most recent business continuity and disaster recovery plans.

  • Maintenance Program LESSEE's Maintenance Program

  • Disaster Recovery and Business Continuity The Parties shall comply with the provisions of Schedule 5 (Disaster Recovery and Business Continuity).

Time is Money Join Law Insider Premium to draft better contracts faster.